Skip to content
DraconiticResearch
Search Sources API
210,089 studies31 sourcesUpdated 40 min ago
Peer-reviewedCC BY-NC-ND 4.0Scientific Reports

Modulation of inflammatory pain by myeloid FABP5

  1. 1Department of Anesthesiology, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY USA
  2. 2Stony Brook University Pain and Analgesia Research Center (SPARC), Renaissance School of Medicine, Stony Brook University, Stony Brook, NY USA

Abstract

The initiation and maintenance of pain involves complex neuroimmune interactions, with myeloid cell output finetuning the balance between pronociceptive and antinociceptive signaling. Fatty acid binding protein 5 (FABP5) is a lipid chaperone whose inhibition produces antinociceptive effects in models of inflammatory pain. While FABP5 is highly expressed in myeloid cells that are recruited to sites of inflammation, the contribution of myeloid FABP5 to nociception is unknown. Utilizing myeloid-specific FABP5 conditional knockout (cKO) mice, we demonstrate that FABP5+ myeloid cells infiltrate into the paw following the onset of carrageenan-induced inflammation. However, myeloid cell recruitment was unaffected by FABP5 deletion. FABP5 cKO were characterized by attenuated development of inflammatory thermal hyperalgesia, which was observed throughout the experimental time course and was evident in both sexes. Transcriptomic profiling of myeloid cells obtained from carrageenan injected paws identified numerous differentially expressed genes between FABP5 cKO mice and Flox controls. Notably, FABP5 cKO myeloid cells featured elevated expression of interleukin-10 (IL-10) and CD206, indicative of polarization towards an M2-like anti-inflammatory state. Collectively, this study ascribes a new role to myeloid FABP5 in pain modulation, thereby expanding the repertoire of cell-types wherein FABP5 regulates nociception to myeloid cells.

Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1038/s41598-026-65946-y.

Related

  1. Myeloid AEG-1 regulates the initiation of chronic inflammatory pain responses in the CFA mouse model
    Bryan D. Mckiver, Deniz Bagdas, Lauren V. Moncayo +7
    Brain, behavior, and immunityPeer-reviewedLicence not statedFull textPhysiologyPMC
  2. Investigating endogenous pain modulation through pupillometry: can pupil size reflect offset analgesia?
    Anna Leonhartsberger, Iwanka Iwanojko, Joëlle Katharina Metzger +2
    Pain reportsPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Pre‐Exercise Conditioned Pain Modulation Is Associated With Exercise‐Induced Hypoalgesia in Patients With Painful Rotator Cuff Tears
    Shota Oda, Masashi Izumi, Tomoki Horino +5
    European journal of pain (London, England)Peer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  4. Effects of azacitidine combined with venetoclax on inflammatory markers and overall response rate in elderly patients with newly diagnosed acute myeloid leukemia
    Hui-Fang Liu, Cheng Lian, Xian-Guang Zhu
    BMC GeriatricsPeer-reviewedCC BYFull textGeneral medicineDOAJ
  5. Editorial: Pharmacological modulation of inflammatory pathways in sepsis: targeting the cytokine storm and septic oxidative stress
    Gavin Zhang, Hanna VanBramer, Dawei Wang +2
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Full textEpidemiology & public healthCrossref
BibTeX
@article{doswell2026modulation,
  title = {{Modulation of inflammatory pain by myeloid FABP5}},
  author = {Faniya Doswell and Livia Schutz and Martin Kaczocha},
  journal = {Scientific Reports},
  year = {2026},
  month = aug,
  doi = {10.1038/s41598-026-65946-y},
  url = {https://doi.org/10.1038/s41598-026-65946-y},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - Modulation of inflammatory pain by myeloid FABP5
AU  - Faniya Doswell
AU  - Livia Schutz
AU  - Martin Kaczocha
PY  - 2026
DA  - 2026/08/06
JO  - Scientific Reports
DO  - 10.1038/s41598-026-65946-y
UR  - https://doi.org/10.1038/s41598-026-65946-y
AB  - The initiation and maintenance of pain involves complex neuroimmune interactions, with myeloid cell output finetuning the balance between pronociceptive and antinociceptive signaling. Fatty acid binding protein 5 (FABP5) is a lipid chaperone whose inhibition produces antinociceptive effects in models of inflammatory pain. While FABP5 is highly expressed in myeloid cells that are recruited to sites of inflammation, the contribution of myeloid FABP5 to nociception is unknown. Utilizing myeloid-specific FABP5 conditional knockout (cKO) mice, we demonstrate that FABP5+ myeloid cells infiltrate into the paw following the onset of carrageenan-induced inflammation. However, myeloid cell recruitment was unaffected by FABP5 deletion. FABP5 cKO were characterized by attenuated development of inflammatory thermal hyperalgesia, which was observed throughout the experimental time course and was evident in both sexes. Transcriptomic profiling of myeloid cells obtained from carrageenan injected paws identified numerous differentially expressed genes between FABP5 cKO mice and Flox controls. Notably, FABP5 cKO myeloid cells featured elevated expression of interleukin-10 (IL-10) and CD206, indicative of polarization towards an M2-like anti-inflammatory state. Collectively, this study ascribes a new role to myeloid FABP5 in pain modulation, thereby expanding the repertoire of cell-types wherein FABP5 regulates nociception to myeloid cells.  Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1038/s41598-026-65946-y.
SN  - 2045-2322
ER  -